NASDAQ · WORX
SCWorx Corp.
$1.82-$0.09 (-4.71%)
SCWorx Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
Loading market information…
NYSE · CCM · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Concord Medical Services Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.18% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Concord Medical Services Holdings Limited’s forward annual dividend is $7.10 per share, paid annual. The forward yield is 193.99% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Concord Medical Services Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.82-$0.09 (-4.71%)
SCWorx Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
$0.85-$0.09 (-9.66%)
Celularity Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.69% below the high.
$0.73-$0.16 (-17.87%)
Syra Health Corp. Class A Common Stock’s quoted price sits in the upper half of its reported 52-week range, 36.43% below the high.
$0.54-$0.02 (-3.6%)
INVO Fertility, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.98% below the high.
$0.14-$0.01 (-6.67%)
Hepion Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 36.36% below the high.
$0.00$0.00 (0.0%)
Aditxt, Inc.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
$0.11$0.00 (0.0%)
Longevity Health Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.41% below the high.
$0.31$0.00 (0.0%)
Shineco, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.42% below the high.
